PMID- 12917077 OWN - NLM STAT- MEDLINE DCOM- 20031020 LR - 20220408 IS - 1530-891X (Print) IS - 1530-891X (Linking) VI - 9 IP - 2 DP - 2003 Mar-Apr TI - Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of the literature. PG - 140-6 AB - OBJECTIVE: To describe a case of a 46-year-old woman with Graves' disease and reversible low-output congestive heart failure and present a comparative analysis of 23 similar cases reported in the literature. METHODS: A detailed case report is presented. In addition, a review of the pertinent literature published between 1960 and 2002 was performed to identify similar cases of dilated cardiomyopathy and thyrotoxicosis and to assess the findings in these patients. RESULTS: A 46-year-old woman without primary heart disease was admitted to the hospital with Graves' thyrotoxicosis and severe low-output congestive heart failure. Her left ventricular ejection fraction (LVEF) at the time of initial assessment was less than 20%, and her condition was categorized as New York Heart Association (NYHA) functional class III. Nineteen months after she was treated for hyperthyroidism, her LVEF was 49% and her status was NYHA class I. A severe hypotensive episode occurred when b-adrenergic blockade therapy was initiated. The group of 23 similar cases from the literature plus our currently described patient had a mean age of 45 years, a male-to-female ratio of 1:1.2, Graves' disease as the principal cause, and LVEF improvement from 29% to 58%. CONCLUSION: Dilated cardiomyopathy is an unusual manifestation of hyperthyroidism with unclear cause. Clinicians should be aware of this entity because it is treatable and hypotension can occur if b-adrenergic blockade treatment is initiated. FAU - Boccalandro, Cristina AU - Boccalandro C AD - Division of Endocrinology and Metabolism, University of Texas at Houston, Houston, Texas, USA. FAU - Boccalandro, Fernando AU - Boccalandro F FAU - Orlander, Philip AU - Orlander P FAU - Wei, Chik Fong AU - Wei CF LA - eng PT - Case Reports PT - Journal Article PT - Review PL - United States TA - Endocr Pract JT - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists JID - 9607439 RN - 0 (Adrenergic beta-Antagonists) SB - IM MH - Adrenergic beta-Antagonists/adverse effects MH - Cardiac Output MH - Cardiomyopathy, Dilated/*complications/drug therapy/physiopathology MH - Female MH - Humans MH - Hyperthyroidism/*complications MH - Hypotension/chemically induced/physiopathology/therapy MH - Middle Aged RF - 58 EDAT- 2003/08/15 05:00 MHDA- 2003/10/21 05:00 CRDT- 2003/08/15 05:00 PHST- 2003/08/15 05:00 [pubmed] PHST- 2003/10/21 05:00 [medline] PHST- 2003/08/15 05:00 [entrez] AID - S1530-891X(20)40918-8 [pii] AID - 10.4158/EP.9.2.140 [doi] PST - ppublish SO - Endocr Pract. 2003 Mar-Apr;9(2):140-6. doi: 10.4158/EP.9.2.140.